Literature DB >> 2544645

Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression.

K A Clouse1, P B Robbins, B Fernie, J M Ostrove, A S Fauci.   

Abstract

We have previously described model systems for cytokine-induced regulation of chronically HIV-infected promonocyte and T cell clones. Using these systems, we have shown that monokines contained in supernatants from LPS-stimulated human monocyte/macrophages (MO) up-regulate HIV expression, reflected by an increase in reverse transcriptase activity, viral RNA levels, and expressed viral proteins. Current studies were designed to determine whether viral Ag can interact with MO and secondarily affect HIV1 expression by stimulating monokine production. We found that certain herpes-group viruses, including CMV and EBV, augment HIV1 expression by inducing monokine production, whereas others, such as HSV1, HSV2, varicella-zoster virus, and human herpes virus 6 were unable to function in this capacity. The HSV1 and HSV2 Ag which failed to stimulate monokine production did not interfere with MO stimulation by CMV Ag, suggesting that failure to induce HIV expression was not attributable to MO suppression. When nonherpes group viruses were tested, we found that human adenovirus, hepatitis B virus, and vaccinia virus all failed to stimulate the production of monokines capable of activating HIV in the chronically infected cell lines. In contrast, HIV1 can augment its own expression by inducing the secretion of monokines which up-regulate HIV expression in the infected cells. The viral Ag-induced MO supernatants capable of up-regulating HIV expression did so in a dose-dependent manner, whereas viral Ag alone produced no significant change. Monokine production mediated by viral Ag was not attributable to contaminating endotoxin. These studies provide a model to determine whether other opportunistic infections may induce the expression of HIV by indirect mechanisms, such as the stimulation of cytokine production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544645

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

Review 2.  Mixed viral infections: detection and management.

Authors:  J L Waner
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

3.  The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR.

Authors:  S J Brodie; W C Wilson; P M O'Hearn; D Muthui; K Diem; L D Pearson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages.

Authors:  P D Smith; S S Saini; M Raffeld; J F Manischewitz; S M Wahl
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells.

Authors:  J M Molina; D T Scadden; C Amirault; A Woon; E Vannier; C A Dinarello; J E Groopman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses.

Authors:  V Koval; C Clark; M Vaishnav; S A Spector; D H Spector
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

9.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patients.

Authors:  A Webster; A N Phillips; C A Lee; G Janossy; P B Kernoff; P D Griffiths
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.